Pharmaceutical Ethics: Oxymoron or Opportunity?
Einstein/Montefiore Department of Medicine Grand Rounds
Thursday, May 03, 2012
8:00 AM: Forchheimer 3rd Floor Lecture Hall, Einstein
Repeated @ 12:15 PM: Cherhasky Auditorium, Montefiore Medical Center
Speaker & Info
Elizabeth Kitsis, MD, MBE
Assistant Professor, Department of Epidemiology & Population
Assistant Professor, Department of Medicine (Rheumatology)
Albert Einstein College of Medicine/Montefiore Medical Center
Director, Bioethics Education
Montefiore-Einstein Center for Bioethics
Elizabeth A. Kitsis, MD, MBE completed her medical education at Cornell University Medical College, her internal medicine residency at Boston City Hospital, and her fellowship and chief fellowship in rheumatology at New York University Medical Center. After serving as Director of Clinical Research in Rheumatology at NYU, she moved to the pharmaceutical industry in 1993 to become Associate Medical Director. She rose through the ranks at Pfizer over the next ten years, ultimately becoming Vice President of Worldwide Development, with responsibility for the medical activities related to Pain and Inflammation, Oncology, and Diversified Products. While at Pfizer, Dr. Kitsis developed an interest in research ethics, and introduced a course on this topic for the company. Dr. Kitsis left Pfizer to pursue a Master of Bioethics degree at the University of Pennsylvania.
Dr. Kitsis assumed her current position at Einstein in 2008 as the Director of Bioethics Education. She is also a faculty member of the Montefiore-Einstein Center for Bioethics, and has developed and taught a course on Pharmaceutical Ethics for its master's program. Dr. Kitsis has published in the areas of pharmaceutical ethics, professionalism, and bioethics education. She has served on the Ethics and Conflict of Interest Committee of the American College of Rheumatology, and is currently a member of the Bioethics Committee at Einstein-Montefiore, the Committee on Conflict of Interest, and the Committee on Ethical Research Performance. She is also Fellow of the American College of Rheumatology and a practicing rheumatologist.
Objectives - After attending this activity, participants will be able to:
- Appreciate the steps involved in drug development
- Recognize the potential ethical pitfalls in the drug development and commercialization process
- Gain insight into pharmaceutical ethics--an approach that incorporates the moral responsibility of corporations into the drug development process
Accreditation: Albert Einstein College of Medicine designates this educational activity for a maximum of 1 credit towards the AMA Physician's
Recognition Award. Each physician should claim only those credits that he/she actually spent in the educational activity.
Department of Medicine